Overview

Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease

Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
one year extension study following a previous double-blind study to evaluate safety of the drug
Phase:
Phase 3
Details
Lead Sponsor:
University Health Network, Toronto
Collaborator:
Eisai Inc.
Treatments:
Donepezil